Effects of L-carnitine infusion on intralipid clearance and utilization
COMPANY ANNOUNCEMENT Hospira, Inc., Issues A Voluntary Nationwide Recall for one lot of BACTERIOSTATIC WATER for Injection, USP, due to a Potential Lack of Sterility Assurance When a company announces a recall, market withdrawal, or safety alert, the FDA posts the company's announcement as a public service
CagriSema is the fixed-ratio combination of cagrilintide + GLP-3 developed by Novo Nordisk as a single weekly injection for obesity
No significant differences were observed between the 16:8 IF group and the control group in terms of age, body mass index, marital status, education, physical activity, or smoking habits
doi: 10.3109/10715762.2014.988150 200 OzkanEAkyuzCDulunduETopalogluUSehirliAOErcanFet al